Real-world clinical outcomes of biologic-naive non-complicated Crohn's disease patients treated with vedolizumab: Results from the EVOLVE study

被引：0
|
作者：
Yarur, A. [1 ]
Mantzaris, G. J. [2 ]
Kopylov, U. [3 ]
Bassel, M. [4 ]
Brett, N. [4 ]
Kim, H. [5 ]
Lopez, C. [6 ]
Saha, S. [7 ]
Kifnidi, C. [8 ]
Agboton, C. [9 ]
Adsul, S. [9 ]
Demuth, D. [10 ]
Luo, M. [11 ]
Wang, S. [11 ]
Bressler, B. [12 ]
机构：
[1] Med Coll Wisconsin, Gastroenterol, Milwaukee, WI 53226 USA
[2] Evangelismos Med Ctr, Gastroenterol, Athens, Greece
[3] Sheba Med Ctr, Gastroenterol, Tel Aviv, Israel
[4] Evidera, Real World Evidence, Montreal, PQ, Canada
[5] Evidera, Data Analyt, Waltham, MA USA
[6] Takeda Pharmaceut USA Inc, Med Affairs, Deerfield, IL USA
[7] Takeda Canada Inc, Med Affairs, Oakville, ON, Canada
[8] Takeda Hellas SA, Med Affairs, Athens, Greece
[9] Takeda Pharmaceut Int AG, Global Med Affairs, Zurich, Switzerland
[10] Takeda Pharmaceut Int, Evidence Generat & Publicat, Singapore, Singapore
[11] Takeda Pharmaceut Int, Global Outcomes Res, Boston, MA USA
[12] St Pauls Hosp, Gastroenterol, Vancouver, BC, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P387
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD CLINICAL OUTCOMES OF BIOLOGIC-NAIVE NON-COMPLICATED CROHN'S DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: RESULTS FROM THE EVOLVE STUDY
    Yarur, Andres J.
    Mantzaris, Gerassimos J.
    Kopylov, Uri
    Bassel, Marielle
    Brett, Neil R.
    Kim, Hankyul
    Lopez, Claudia
    Saha, Sumit
    Kifnidi, Christina
    Agboton, Christian
    Adsul, Shashi
    Demuth, Dirk
    Luo, Michelle
    Wang, Song
    Bressler, Brian
    GASTROENTEROLOGY, 2020, 158 (06) : S932 - S933
  • [2] Real-world clinical outcomes of biological therapy-naive patients with non-complicated Crohn's disease treated with vedolizumab: Results from the EVOLVE study
    Yarur, A.
    Mantzaris, G.
    Kopylov, U.
    Bassel, M.
    Brett, N.
    Kim, H.
    Lopez, C.
    Saha, S.
    Kifnidi, C.
    Agboton, C.
    Adsul, S.
    Demuth, D.
    Luo, M.
    Wang, S.
    Bressler, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 121 - 121
  • [3] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 768 - 769
  • [4] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study
    Ferrante, M.
    Christensen, B.
    Bressler, B.
    Brett, N.
    Bassel, M.
    Kamble, P.
    Adsul, S.
    Gianchetti, L.
    Scharl, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 116 - 117
  • [5] REAL-WORLD CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN BIOLOGIC-NAIVE PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE EVOLVE EXPANSION STUDY
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Bassel, Marielle
    Kamble, Pravin
    Adsul, Shashi
    Gianchetti, Lauren
    Scharl, Michael M.
    GASTROENTEROLOGY, 2023, 164 (06) : S5 - S5
  • [6] Real World Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-Naive Patients With Crohn's Disease: Results From the EVOLVE Study
    Yarur, Andres
    Bressler, Brian
    Brett, Neil
    Bassel, Marielle
    Adsul, Shashi
    Kamble, Pravin
    Mantzaris, Gerassimos J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S627 - S628
  • [7] Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease by disease location: Results from the EVOLVE Expansion study
    Scharl, M.
    Christensen, B.
    Bressler, B.
    Brett, N. R.
    Gianchetti, L.
    Kamble, P.
    Adsul, S.
    Farhat, Z.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1194 - I1195
  • [8] Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naive Patients With Non-Complicated Crohn's Disease: Results From the EVOLVE Expansion Study
    Ferrante, Marc
    Christensen, Britt
    Bressler, Brian
    Brett, Neil R.
    Gianchetti, Lauren
    Kamble, Pravin
    Adsul, Shashi
    Farhat, Zeinab
    Scharl, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S855 - S856
  • [9] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
    Bressler, B.
    Mantzaris, G.
    Silverberg, M.
    Zezos, P.
    Stein, D.
    Colby, C.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Yarur, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S427 - S428
  • [10] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
12345